Refine your results

to


Search

Despite requests, many women with breast cancer do not receive genetic tests

Show Citation

February 7, 2017

AUTHORS:

Kurian AW, Griffith KA, Hamilton AS, Ward KC, Morrow M, Katz SJ, Jagsi R.

BACKGROUND:

Germline genetic testing of patients with breast cancer is an important model of how increasingly widespread genomic sequencing can influence treatment decision making. Testing of BRCA1 and BRCA 2 has been available for 20 years, but new massively parallel sequencing technology and less restrictive patent laws have made multiple panel tests available at much lower costs. ...

Advertisement
Advertisement